Skip to main navigation Skip to search Skip to main content

Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer

  • Benjamin A. Gartrell
  • , Mack Roach
  • , Avi Retter
  • , Gerald H. Sokol
  • , Giuseppe Del Priore
  • , Howard I. Scher
  • , Howard I. Scher
  • Albert Einstein College of Medicine
  • University of California, San Francisco
  • NY Cancer and Blood Specialist, East Setauket, USA
  • Division of Clinical Pharmacology, Uniform Services University of the Health Sciences, Bethesda, USA
  • TYME Inc, New York, USA
  • Cornell University
  • Memorial Sloan-Kettering Cancer Center

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalInvestigational New Drugs
Volume39
Issue number2
DOIs
StatePublished - Apr 1 2021
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Urology

Cite this